Author:
Hofmann Johann,Easmon Johnny,Puerstinger Gerhard,Heinisch Gottfried,Jenny Marcel,Shtil Alexander A.,Hermann Martin,Condorelli Daniele F.,Sciré Salvatore,Musumarra Giuseppe
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Oncology
Reference42 articles.
1. Mauro MJ, O’Dwyer M, Heinrich MC, Druker BJ (2002) STI571: a paradigm of new agents for cancer therapeutics. J Clin Oncol 20(1):325–334 doi: 10.1200/JCO.20.1.325
2. Folkman J (2001) Angiogenesis-dependent diseases. Semin Oncol 28(6):536–542 doi: 10.1016/S0093-7754(01)90021-1
3. Lothstein L, Israel M, Sweatman TW (2000) Anthracycline drug targeting: cytoplasmic versus nuclear—a fork in the road. Drug Resist Updat 14:169–177
4. Jansen B, Wacheck V, Heere-Ress E, Schlagbauer-Wadl H, Hoeller C, Lucas T et al (2000) Chemosensitisation of malignant melanoma by BCL2 antisense therapy. Lancet 356(9243):1728–1733 doi: 10.1016/S0140-6736(00)03207-4
5. Yuen AR, Halsey J, Lum B, Fisher G, Holmlund JT, Geary R et al (1999) Phase I study of an antisense oligonucleotide to protein kinase C-α, (ISIS 3521/CGP64128A) in patients with cancer. Clin Cancer Res 5(11):3357–3363
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献